A Case of Cold Agglutinin Disease
Continuing Education Credits
Objectives
- Define cold agglutinin disease and outline the etiology of this disorder, with a focus on primary (idiopathic) versus secondary conditions.
- Differentiate between acute and chronic cold agglutinin disease.
- Outline the potential clinical features (signs, symptoms, pathophysiology) associated with cold agglutinin disease.
- Evaluate hematology parameters and identify potentially skewed results due to a cold agglutinin.
- Compare erroneous laboratory results caused by cold agglutinin disease to other potential patient sample interferences (i.e., proteinemia, lipemia).
- Determine pre-examination specimen handling to correct for cold agglutinin interference.
Course Outline
- Cold Agglutinin Disease
- Introduction to Cold Agglutinin Disease
- Cold Agglutinin Disease
- Introduction to Autoantibody Production
- Autoantibodies in Cold Agglutinin Disease
- Pathophysiology
- Pathophysiology
- The immunoglobulin class most associated with cold agglutinin disease is:
- Symptoms of CAD
- Etiology
- Etiology
- Primary CAD
- Secondary CAD
- All of the following diagnoses could result in the production of cold agglutinins except:
- Epidemiology
- Incidence, Prevalence, and Prognosis
- Monitoring and Treatment
- Monitoring and Treatment
- Lab Considerations
- Pre-Testing Considerations in the Hematology Laboratory
- Correcting an In Vitro Cold Agglutinin
- Pre-Examination Interferences and Differentiating CAD
- Pre-Examination Interferences and Comparison of Correction Techniques
- The following technique would be most helpful in quickly identifying a cold agglutinin:
- Case Study
- Case Study: A Patient with Cold Agglutinin Disease
- Initial Results
- Rule of Three
- Review the following CBC results. Which of the listed parameters violates the rule of three?ParameterResultReference RangeWBC5.804.0–10.0 × 103/mcLRBC1.43M: 4.6–6.1 × 106/mcL F: 3.9–5.2 × 106/mcL Hb12.3M: 14–18 g/dL F: 11–16 g/dL Hct13.5M: 40–51% F: 34–45% MCV94.4M: 80–94 fL F: 81–99 fL MCH86.027–35 pgMCHC91.133–36 g/
- Technical Considerations and Cause of False Parameters
- What do we know about the technology for measuring hemoglobin that explains why this parameter is not affected by cold agglutinin?
- Post-Incubation Results
- Evaluating Results of Post-Sample Treatment
- Analyzer Results
- Confirmation Testing
- Laboratory Confirmation
- Additional Laboratory Testing for Diagnosis
- All of the following test results correlate with a diagnosis of CAD after a hemolytic episode except:
- References
- References

